The journal of spinal cord medicine · 2024
Validation of the Patient Activation Measure (PAM-13) among individuals with chronic spinal cord injury in mainland China.
СтатьяВалидационное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Xie Hai-Xia, Wu Ai-Rong, Xu Zi-Han, Zhang Qi, Wang Xin-Yu, Yu Hao, Li Nan, Wei Yan, Li Xiao-Hong, Zhai Hua, Chang Feng-Shui
Аннотация
CONTEXT/OBJECTIVE: The 13-item Patient Activation Measure (PAM-13) is the most widely used generic patient activation measure, but spinal cord injury (SCI) related psychometric evaluation of PAM-13 has not been explored globally. This study aimed to assess the validity of the Chinese version of the PAM-13 (PAM-13-C) for individuals with chronic spinal cord injury (CSCI).
DESIGN: Cross-sectional study.
SETTING: Shanghai Sunshine Rehabilitation Center, and some participants were recruited in a WeChat group (the most commonly used social media platform in China).
PARTICIPANTS: 284 individuals with spinal cord injury who had lived with the injury for ≥0.5 year.
INTERVENTIONS: NA.
OUTCOME MEASURES: The PAM-13-C, global QoL, seven-item generalized anxiety disorder scale (GAD-7) and nine-item patient health questionnaire (PHQ-9), and General Self-Efficacy Scale (GSES) were used.
RESULTS: The mean (SD) PAM-13-C score was 57.4 (16.5). The highest percentage of NA could be observed in item 9 (12.0%). Floor and ceiling effects of the total scores of PAM-13-C were small (0.7% and 6.7%), but a ceiling effect could be observed among all items. Exploratory Factor Analysis supported a one-factor model of the PAM-13-C (CFI = 0.97; RMSEA = 0.07). Construct validity was established through correlation analysis among the PAM-13-C, GAD-7/PHQ-9, global QoL, and GSES. The PAM-13-C demonstrated excellent internal consistency (Cronbach's α = 0.95) and acceptable test-retest reliability.
CONCLUSION: The PAM-13-C is a reliable and valid measure of patient activation for individuals with CSCI in China.
DESIGN: Cross-sectional study.
SETTING: Shanghai Sunshine Rehabilitation Center, and some participants were recruited in a WeChat group (the most commonly used social media platform in China).
PARTICIPANTS: 284 individuals with spinal cord injury who had lived with the injury for ≥0.5 year.
INTERVENTIONS: NA.
OUTCOME MEASURES: The PAM-13-C, global QoL, seven-item generalized anxiety disorder scale (GAD-7) and nine-item patient health questionnaire (PHQ-9), and General Self-Efficacy Scale (GSES) were used.
RESULTS: The mean (SD) PAM-13-C score was 57.4 (16.5). The highest percentage of NA could be observed in item 9 (12.0%). Floor and ceiling effects of the total scores of PAM-13-C were small (0.7% and 6.7%), but a ceiling effect could be observed among all items. Exploratory Factor Analysis supported a one-factor model of the PAM-13-C (CFI = 0.97; RMSEA = 0.07). Construct validity was established through correlation analysis among the PAM-13-C, GAD-7/PHQ-9, global QoL, and GSES. The PAM-13-C demonstrated excellent internal consistency (Cronbach's α = 0.95) and acceptable test-retest reliability.
CONCLUSION: The PAM-13-C is a reliable and valid measure of patient activation for individuals with CSCI in China.